Pulmonary syndrome and intravenous high-dose desferrioxamine
Lancet
.
1990 Dec 15;336(8729):1511.
doi: 10.1016/0140-6736(90)93217-d.
Authors
A Castriota Scanderbeg
,
G C Izzi
,
A Butturini
,
G Benaglia
PMID:
1979119
DOI:
10.1016/0140-6736(90)93217-d
No abstract available
Publication types
Letter
MeSH terms
Adolescent
Child
Deferoxamine / administration & dosage*
Deferoxamine / adverse effects
Humans
Infusions, Intravenous
Pulmonary Fibrosis / chemically induced*
Thalassemia / drug therapy*
Substances
Deferoxamine